Cargando…

The Natural History and Reperfusion Therapy Outcomes of Acute Ischemic Stroke due to Isolated M2 Occlusions

OBJECTIVE: Currently, the standard treatment modality for patients with acute ischemic stroke (AIS) presenting with isolated M2 occlusions is not specific. We therefore assessed the difference in treatment outcomes for patients with isolated M2 occlusions. METHODS: We retrospectively analyzed consec...

Descripción completa

Detalles Bibliográficos
Autores principales: Gong, Hongmin, Zhao, Libo, Tang, Ge, Chen, Yu, Yang, Deyu, Liu, Shudong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8096556/
https://www.ncbi.nlm.nih.gov/pubmed/33997031
http://dx.doi.org/10.1155/2021/6626604
_version_ 1783688184105795584
author Gong, Hongmin
Zhao, Libo
Tang, Ge
Chen, Yu
Yang, Deyu
Liu, Shudong
author_facet Gong, Hongmin
Zhao, Libo
Tang, Ge
Chen, Yu
Yang, Deyu
Liu, Shudong
author_sort Gong, Hongmin
collection PubMed
description OBJECTIVE: Currently, the standard treatment modality for patients with acute ischemic stroke (AIS) presenting with isolated M2 occlusions is not specific. We therefore assessed the difference in treatment outcomes for patients with isolated M2 occlusions. METHODS: We retrospectively analyzed consecutive patients with AIS presenting with isolated M2 occlusions from October 1, 2018, to June 30, 2020. Patients were divided into 3 groups based on the treatments they received: no reperfusion therapy (NRT), intravenous thrombolysis treatment (IVT), and endovascular intervention (EVT), which comprised IVT in conjunction with EVT or EVT alone. The primary outcomes were improvements in modified Rankin Scale (mRS) scores at 90 days and National Institutes of Health Stroke Scale (NIHSS) scores at 24 hours after treatment compared with the baseline. The secondary efficacy outcome comprised a good outcome rate defined as a 90 − day mRS score ≤ 2, final infarct volume (FIV), 90-day mortality rate, and successful recanalization rate, which was defined as a modified thrombolysis in cerebral infarction score ≥ 2b. Safety outcomes included symptomatic intracerebral hemorrhage and procedure-related complications. RESULTS: Seventy patients were enrolled and divided into 3 groups: the NRT group (n = 25), IVT group (n = 27), and EVT group (n = 18). Twenty-four-hour posttreatment NIHSS scores were substantially decreased by EVT compared with NRT (adjusted β -4.01, 95% confidence interval [CI] -6.60 to -1.43; P = 0.003) or IVT (adjusted β, -3.61 [95% CI, -6.45 to -0.77]; P = 0.013). Compared with the outcomes observed after NRT, patients who received EVT were more likely to achieve lower 90-day mRS scores (adjusted β, -1.42 [95% CI, -2.66 to -0.63]; P = 0.007), higher good outcome rates (adjusted odds ratio, 8.73 [95% CI, 1.43-53.24]; P = 0.019), and smaller FIVs (adjusted β, -29.66 [95% CI, -59.73 to 0.42]; P = 0.048). The recanalization rate of EVT was high (88.89%), and procedure-related complications were rare (5.56%). CONCLUSIONS: For acute, isolated M2 occlusions, EVT could dramatically and rapidly improve neurological deficits with high safety and effectiveness. These changes were observed at 24 hours after treatment and were maintained over the long term.
format Online
Article
Text
id pubmed-8096556
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Hindawi
record_format MEDLINE/PubMed
spelling pubmed-80965562021-05-13 The Natural History and Reperfusion Therapy Outcomes of Acute Ischemic Stroke due to Isolated M2 Occlusions Gong, Hongmin Zhao, Libo Tang, Ge Chen, Yu Yang, Deyu Liu, Shudong Biomed Res Int Research Article OBJECTIVE: Currently, the standard treatment modality for patients with acute ischemic stroke (AIS) presenting with isolated M2 occlusions is not specific. We therefore assessed the difference in treatment outcomes for patients with isolated M2 occlusions. METHODS: We retrospectively analyzed consecutive patients with AIS presenting with isolated M2 occlusions from October 1, 2018, to June 30, 2020. Patients were divided into 3 groups based on the treatments they received: no reperfusion therapy (NRT), intravenous thrombolysis treatment (IVT), and endovascular intervention (EVT), which comprised IVT in conjunction with EVT or EVT alone. The primary outcomes were improvements in modified Rankin Scale (mRS) scores at 90 days and National Institutes of Health Stroke Scale (NIHSS) scores at 24 hours after treatment compared with the baseline. The secondary efficacy outcome comprised a good outcome rate defined as a 90 − day mRS score ≤ 2, final infarct volume (FIV), 90-day mortality rate, and successful recanalization rate, which was defined as a modified thrombolysis in cerebral infarction score ≥ 2b. Safety outcomes included symptomatic intracerebral hemorrhage and procedure-related complications. RESULTS: Seventy patients were enrolled and divided into 3 groups: the NRT group (n = 25), IVT group (n = 27), and EVT group (n = 18). Twenty-four-hour posttreatment NIHSS scores were substantially decreased by EVT compared with NRT (adjusted β -4.01, 95% confidence interval [CI] -6.60 to -1.43; P = 0.003) or IVT (adjusted β, -3.61 [95% CI, -6.45 to -0.77]; P = 0.013). Compared with the outcomes observed after NRT, patients who received EVT were more likely to achieve lower 90-day mRS scores (adjusted β, -1.42 [95% CI, -2.66 to -0.63]; P = 0.007), higher good outcome rates (adjusted odds ratio, 8.73 [95% CI, 1.43-53.24]; P = 0.019), and smaller FIVs (adjusted β, -29.66 [95% CI, -59.73 to 0.42]; P = 0.048). The recanalization rate of EVT was high (88.89%), and procedure-related complications were rare (5.56%). CONCLUSIONS: For acute, isolated M2 occlusions, EVT could dramatically and rapidly improve neurological deficits with high safety and effectiveness. These changes were observed at 24 hours after treatment and were maintained over the long term. Hindawi 2021-04-27 /pmc/articles/PMC8096556/ /pubmed/33997031 http://dx.doi.org/10.1155/2021/6626604 Text en Copyright © 2021 Hongmin Gong et al. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Gong, Hongmin
Zhao, Libo
Tang, Ge
Chen, Yu
Yang, Deyu
Liu, Shudong
The Natural History and Reperfusion Therapy Outcomes of Acute Ischemic Stroke due to Isolated M2 Occlusions
title The Natural History and Reperfusion Therapy Outcomes of Acute Ischemic Stroke due to Isolated M2 Occlusions
title_full The Natural History and Reperfusion Therapy Outcomes of Acute Ischemic Stroke due to Isolated M2 Occlusions
title_fullStr The Natural History and Reperfusion Therapy Outcomes of Acute Ischemic Stroke due to Isolated M2 Occlusions
title_full_unstemmed The Natural History and Reperfusion Therapy Outcomes of Acute Ischemic Stroke due to Isolated M2 Occlusions
title_short The Natural History and Reperfusion Therapy Outcomes of Acute Ischemic Stroke due to Isolated M2 Occlusions
title_sort natural history and reperfusion therapy outcomes of acute ischemic stroke due to isolated m2 occlusions
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8096556/
https://www.ncbi.nlm.nih.gov/pubmed/33997031
http://dx.doi.org/10.1155/2021/6626604
work_keys_str_mv AT gonghongmin thenaturalhistoryandreperfusiontherapyoutcomesofacuteischemicstrokeduetoisolatedm2occlusions
AT zhaolibo thenaturalhistoryandreperfusiontherapyoutcomesofacuteischemicstrokeduetoisolatedm2occlusions
AT tangge thenaturalhistoryandreperfusiontherapyoutcomesofacuteischemicstrokeduetoisolatedm2occlusions
AT chenyu thenaturalhistoryandreperfusiontherapyoutcomesofacuteischemicstrokeduetoisolatedm2occlusions
AT yangdeyu thenaturalhistoryandreperfusiontherapyoutcomesofacuteischemicstrokeduetoisolatedm2occlusions
AT liushudong thenaturalhistoryandreperfusiontherapyoutcomesofacuteischemicstrokeduetoisolatedm2occlusions
AT gonghongmin naturalhistoryandreperfusiontherapyoutcomesofacuteischemicstrokeduetoisolatedm2occlusions
AT zhaolibo naturalhistoryandreperfusiontherapyoutcomesofacuteischemicstrokeduetoisolatedm2occlusions
AT tangge naturalhistoryandreperfusiontherapyoutcomesofacuteischemicstrokeduetoisolatedm2occlusions
AT chenyu naturalhistoryandreperfusiontherapyoutcomesofacuteischemicstrokeduetoisolatedm2occlusions
AT yangdeyu naturalhistoryandreperfusiontherapyoutcomesofacuteischemicstrokeduetoisolatedm2occlusions
AT liushudong naturalhistoryandreperfusiontherapyoutcomesofacuteischemicstrokeduetoisolatedm2occlusions